Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3912175, 12 pages
http://dx.doi.org/10.1155/2016/3912175
Review Article

Apolipoprotein E Gene Variants and Risk of Coronary Heart Disease: A Meta-Analysis

1Key Laboratory of Environmental Medicine Engineering, Ministry of Education, Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing, China
2Graduate School of Peking Union Medical College, Beijing, China
3National Research Institute for Family Planning, Beijing, China
4Centers for Disease Control and Prevention, Zhejiang, China
5Department of Cardiology, ZhongDa Hospital, Southeast University, Nanjing, Jiangsu, China

Received 16 August 2016; Accepted 9 October 2016

Academic Editor: Hai-Feng Pan

Copyright © 2016 Min Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Zhou, X. Chen, H. Ye et al., “An association study between genetic polymorphism in the interleukin-6 receptor gene and coronary heart disease,” BioMed Research International, vol. 2014, Article ID 504727, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. E. F. A. E. Halim, A. A. Reda, A. A. K. Hendi, S. A. Zaki, E. S. Essa, and A. S. Khalifa, “Apolipoprotein E gene variants as a risk factor for coronary artery disease in type 2 diabetic Egyptian patients,” The Egyptian Journal of Immunology, vol. 19, no. 1, pp. 1–10, 2012. View at Google Scholar · View at Scopus
  3. G. D. Kolovou, D. B. Panagiotakos, V. Kolovou et al., “Common variants of apolipoprotein E and cholesteryl ester transport protein genes in male patients with coronary heart disease and variable body mass index,” Angiology, vol. 66, no. 2, pp. 169–173, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Roberts and A. F. R. Stewart, “Genes and coronary artery disease: where are we?” Journal of the American College of Cardiology, vol. 60, no. 18, pp. 1715–1721, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Mi, K. M. Eskridge, V. George, and D. Wang, “Structural equation modeling of gene-environment interactions in coronary heart disease,” Annals of Human Genetics, vol. 75, no. 2, pp. 255–265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Jeemon, K. Pettigrew, C. Sainsbury, D. Prabhakaran, and S. Padmanabhan, “Implications of discoveries from genome-wide association studies in current cardiovascular practice,” World Journal of Cardiology, vol. 3, no. 7, pp. 230–247, 2011. View at Google Scholar
  7. V. Bañares, D. Wyszynski, L. Schreier, and M. Tavella, “APOE -219G/T polymorphism related to serum lipid levels in atherosclerotic patients from Argentina,” Investigacion Clinica, vol. 51, no. 1, pp. 17–26, 2010. View at Google Scholar · View at Scopus
  8. J. T. Bazzaz, M. Nazari, H. Nazem et al., “Apolipoprotein E gene polymorphism and total serum cholesterol level in Iranian population,” Journal of Postgraduate Medicine, vol. 56, no. 3, pp. 173–175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Ken-Dror, P. J. Talmud, S. E. Humphries, and F. Drenos, “APOE/C1/C4/C2 gene cluster genotypes, haplotypes and lipid levels in prospective coronary heart disease risk among UK healthy men,” Molecular Medicine, vol. 16, no. 9-10, pp. 389–399, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Takeuchi, M. Isono, T. Katsuya et al., “Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals,” PLoS ONE, vol. 7, no. 9, article e46385, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. D. Waltmann, J. E. Basford, E. S. Konaniah, N. L. Weintraub, and D. Y. Hui, “Apolipoprotein E receptor-2 deficiency enhances macrophage susceptibility to lipid accumulation and cell death to augment atherosclerotic plaque progression and necrosis,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1842, no. 9, pp. 1395–1405, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Dallongeville, S. Lussier-Cacan, and J. Davignon, “Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis,” Journal of Lipid Research, vol. 33, no. 4, pp. 447–454, 1992. View at Google Scholar · View at Scopus
  13. P. W. F. Wilson, E. J. Schaefer, M. G. Larson, and J. M. Ordovas, “Apolipoprotein E alleles and risk of coronary disease: a meta-analysis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 10, pp. 1250–1255, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. A. N. Cheema, A. Bhatti, X. Wang et al., “APOE gene polymorphism and risk of coronary stenosis in Pakistani population,” BioMed Research International, vol. 2015, Article ID 587465, 5 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Zhang, H. Q. Tang, W. J. Peng, B. B. Zhang, and M. Liu, “Meta-analysis for the association of apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphism with coronary heart disease,” Chinese Medical Journal, vol. 128, pp. 1391–1398, 2015. View at Google Scholar
  16. M.-D. Zhang, W. Gu, S.-B. Qiao, E.-J. Zhu, Q.-M. Zhao, and S.-Z. Lv, “Apolipoprotein e gene polymorphism and risk for coronary heart disease in the chinese population: a meta-analysis of 61 studies including 6634 cases and 6393 controls,” PLoS ONE, vol. 9, no. 4, article e95463, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. L. F. Marrzoq, F. A. Sharif, and A. A. Abed, “Relationship between ApoE gene polymorphism and coronary heart disease in Gaza Strip,” Journal of Cardiovascular Disease Research, vol. 2, no. 1, pp. 29–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C.-H. Wang, X. Zhou, G.-D. Zhou, D.-F. Han, and F. Zheng, “Interaction of ApoE and LDL-R gene polymorphisms and alcohol drinking and smoking on coronary heart disease,” Zhonghua Yi Xue Za Zhi, vol. 84, no. 7, pp. 554–558, 2004. View at Google Scholar · View at Scopus
  19. X. Bai, M. Zhao, and B. Wang, “Dyslipidemia-related risk factors for myocardial infarction and polymorphism of ApoE gene among myocardial infarction patients and their siblings,” Zhonghua yi xue za zhi, vol. 81, no. 6, pp. 340–343, 2001. View at Google Scholar · View at Scopus
  20. C.-H. Wang, X. Zhou, G.-D. Zhou et al., “Genetic association of apoE and apoCI gene polymorphisms with coronary heart disease,” Zhonghua Liu Xing Bing Xue Za Zhi, vol. 25, no. 11, pp. 982–985, 2004. View at Google Scholar · View at Scopus
  21. S. Peng, J. Peng, and W. Gong, “Association of apolipoprotein E gene polymorphism with early-onset coronary heart disease and its effect on plasma lipid levels,” Zhonghua Yi Xue Yi Chuan Xue Za Zhi, vol. 18, no. 5, pp. 375–378, 2001. View at Google Scholar · View at Scopus
  22. Z. Yang, T. Zhu, G. Ma et al., “Apolipoprotein E polymorphism in the early onset of coronary heart disease,” Chinese Medical Journal, vol. 114, no. 9, pp. 983–985, 2001. View at Google Scholar · View at Scopus
  23. T. Ouyang, J.-N. Song, Y. Miao et al., “Study on relationship between polymorphism of apolipoprotein E gene and syndromes of phlegm and blood stasis in patients with coronary heart disease,” Zhong Xi Yi Jie He Xue Bao, vol. 3, no. 6, pp. 438–442, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Heide, K. Manfred, C. Gläser, and S. Schulz, “Apolipoprotein E (apoE) polymorphism: a risk factor for fatal coronary sclerosis?” Forensic Science International, vol. 192, no. 1–3, pp. 62–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. G. D. Kolovou, K. K. Anagnostopoulou, P. Kostakou et al., “Apolipoprotein E gene polymorphism and obesity status in middle-aged men with coronary heart disease,” In Vivo, vol. 23, no. 1, pp. 33–39, 2009. View at Google Scholar · View at Scopus
  26. R. Bahri, E. Esteban, P. Moral, M. Hassine, K. B. Hamda, and H. Chaabani, “Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease,” Lipids in Health and Disease, vol. 7, article 46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. O. Akanji, C. G. Suresh, H. R. Fatania, R. Al-Radwan, and M. Zubaid, “Associations of apolipoprotein E polymorphism with low-density lipoprotein size and subfraction profiles in Arab patients with coronary heart disease,” Metabolism: Clinical and Experimental, vol. 56, no. 4, pp. 484–490, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Y. Aydogan, S. Isbir, O. Kurnaz, U. Gormus, and T. Isbir, “Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease,” In Vivo, vol. 23, pp. 155–161, 2009. View at Google Scholar
  29. N. Ranjith, R. J. Pegoraro, L. Rom, M. C. Rajput, and D. P. Naidoo, “Lp(a) and apoE polymorphisms in young South African Indians with myocardial infarction,” Cardiovascular Journal of South Africa, vol. 15, no. 3, pp. 111–117, 2004. View at Google Scholar · View at Scopus
  30. D.-Q. Peng, S.-P. Zhao, S. Nie, and J. Li, “Gene-gene interaction of PPARγ and ApoE affects coronary heart disease risk,” International Journal of Cardiology, vol. 92, no. 2-3, pp. 257–263, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Singh, M. Singh, D. Bhatnagar, T. Kaur, and S. Gaur, “Apolipoprotein E polymorphism and its relation to plasma lipids in coronary heart disease,” Indian Journal of Medical Sciences, vol. 62, no. 3, pp. 105–112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Keavney, S. Parish, A. Palmer et al., “Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E ε2/ε3/ε4 genotype,” The Lancet, vol. 361, no. 9355, pp. 396–398, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. E. M. Freitas, T. C. A. Phan, C. E. Herbison, F. T. Christiansen, R. R. Taylor, and F. M. Van Bockxmeer, “The poliovirus receptor related 2 (PRR2) and apolipoprotein E genes and coronary heart disease,” Journal of Cardiovascular Risk, vol. 9, no. 1, pp. 59–65, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Kawakami, K. Okumura, H. Matsui et al., “The apolipoprotein E genotype influences the risk for vasospastic angina,” Canadian Journal of Cardiology, vol. 17, no. 6, pp. 660–666, 2001. View at Google Scholar · View at Scopus
  35. G. Attila, E. Acartürk, G. Eskandari et al., “Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern Turkey,” Clinica Chimica Acta, vol. 312, no. 1-2, pp. 191–196, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Kharrazi, A. Vaisi Raygani, A. R. Sabokroh, and T. Pourmotabbed, “Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran,” Clinical Biochemistry, vol. 39, no. 6, pp. 613–616, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Gamboa, C. Huesca-Gómez, O. Pérez-Méndez et al., “Apolipoprotein E polymorphisms in Mexican patients with coronary artery disease,” Clinical Chemistry and Laboratory Medicine, vol. 46, no. 4, pp. 481–485, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. S. A. S. Al-Yahyaee, S. S. Ganguly, M. N. Al-Kindi, and A. I. Al-Bahrani, “Apolipoprotein E polymorphism in omani dyslipidemic patients with and without coronary artery disease,” Human Biology, vol. 79, no. 1, pp. 93–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. S. A. Al-Bustan, M. Alkhalaf, I. Al-Rashdan et al., “Apolipoprotein E, CI and B gene polymorphisms in a sample of patients with coronary heart disease in the Kuwaiti population,” Medical Principles and Practice, vol. 18, no. 4, pp. 294–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Vaisi-Raygani, Z. Rahimi, H. Tavilani, and T. Pourmotabbed, “Butyrylcholinesterase K variant and the APOE-ε4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients,” Molecular Biology Reports, vol. 37, no. 4, pp. 2083–2091, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Corella, O. Portolés, L. Arriola et al., “Saturated fat intake and alcohol consumption modulate the association between the APOE polymorphism and risk of future coronary heart disease: a nested case-control study in the Spanish EPIC cohort,” Journal of Nutritional Biochemistry, vol. 22, no. 5, pp. 487–494, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Fallah, M. Seifi, M. Firoozrai, L. Hosainnee Ghohari, A. Samadikuchaksaraei, and B. Samadirad, “Effect of Apolipoprotein E genotypes on incidence and development of coronary stenosis in Iranian patients with coronary artery disease,” Journal of Clinical Laboratory Analysis, vol. 25, no. 1, pp. 43–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Gustavsson, K. Mehlig, K. Leander et al., “Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women,” Atherosclerosis, vol. 220, no. 2, pp. 486–492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Machal, A. Vasku, O. Hlinomaz, P. Linhartova, L. Groch, and J. Vitovec, “Apolipoprotein E polymorphism is associated with both number of diseased vessels and extent of coronary artery disease in Czech patients with CAD,” Biomedical Papers, vol. 156, no. 2, pp. 151–158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. M. M. Heidari, S. K. Foruzannia, M. Khatami, M. Hadadzadeh, and M. Emami Meybodi, “Apolipoprotein E gene polymorphism in Iranian coronary atherosclerosis patients candidate for coronary artery bypass graft,” Iranian Journal of Basic Medical Sciences, vol. 16, no. 7, pp. 841–844, 2013. View at Google Scholar · View at Scopus
  46. D. Afroze, A. Yousuf, N. A. Tramboo, Z. A. Shah, and A. Ahmad, “ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population,” Clinical and Experimental Medicine, vol. 16, no. 4, pp. 551–556, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Sapkota, A. Subramanian, G. Priamvada et al., “Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population,” Journal of Diabetes and Its Complications, vol. 29, no. 8, pp. 1191–1197, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Liu, C. Bian, J. Zhang, and F. Wen, “Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis,” Scientific Reports, vol. 4, article 4383, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Liu, J.-T. Yu, H.-F. Wang et al., “APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 86, no. 2, pp. 127–134, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Chaudhary, A. Likidlilid, T. Peerapatdit et al., “Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease,” Cardiovascular Diabetology, vol. 11, article 36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Davignon, R. E. Gregg, and C. F. Sing, “Apolipoprotein E polymorphism and atherosclerosis,” Arteriosclerosis, vol. 8, no. 1, pp. 1–21, 1988. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Davignon, J. S. Cohn, L. Mabile, and L. Bernier, “Apolipoprotein E and atherosclerosis: insight from animal and human studies,” Clinica Chimica Acta, vol. 286, no. 1-2, pp. 115–143, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. M. H. Moghadasian, B. M. McManus, L. B. Nguyen et al., “Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans,” The FASEB Journal, vol. 15, no. 14, pp. 2623–2630, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. A. K. Stannard, D. R. Riddell, S. M. Sacre et al., “Cell-derived Apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells,” Journal of Biological Chemistry, vol. 276, no. 49, pp. 46011–46016, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. L. G. Shewan and A. J. S. Coats, “Ethics in the authorship and publishing of scientific articles,” International Journal of Cardiology, vol. 144, no. 1, pp. 1–2, 2010. View at Publisher · View at Google Scholar · View at Scopus